Relapsed or Refractory Hodgkin's Lymphoma
Also known as: Relapsed or Refractory Hodgkin Lymphoma
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB11595 | Atezolizumab | 1 / 2 | Recruiting | 1 |
DB06769 | Bendamustine | 1 / 2 | Recruiting | 1 |
DB08870 | Brentuximab vedotin | 1 / 2 | Completed | 1 |
DB00441 | Gemcitabine | 1 / 2 | Recruiting | 1 |
DB17517 | Retlirafusp alfa | 1 / 2 | Recruiting | 1 |
DB00361 | Vinorelbine | 1 / 2 | Recruiting | 1 |
DB17404 | AFM-13 | 2 | Recruiting | 1 |
DB00531 | Cyclophosphamide | 2 | Recruiting | 1 |
DB00997 | Doxorubicin | 2 | Recruiting | 1 |
DB01073 | Fludarabine | 2 | Recruiting | 1 |
DB00441 | Gemcitabine | 2 | Recruiting | 1 |
DB14865 | Human interleukin-2 | 2 | Recruiting | 1 |
DB09037 | Pembrolizumab | 2 | Recruiting | 1 |
DB08877 | Ruxolitinib | 2 | Completed | 1 |
DB00361 | Vinorelbine | 2 | Recruiting | 1 |
DB08870 | Brentuximab vedotin | Not Available | Unknown Status | 1 |